-
13 Comments
Abbott Laboratories is currently in a long term uptrend where the price is trading 4.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.
Abbott Laboratories's total revenue rose by 28.7% to $11B since the same quarter in the previous year.
Its net income has increased by 106.1% to $2B since the same quarter in the previous year.
Finally, its free cash flow grew by 57.4% to $3B since the same quarter in the previous year.
Based on the above factors, Abbott Laboratories gets an overall score of 5/5.
Jack Hardy
Follow
3 years, 3 months ago
|
streamwars
Follow
3 years, 3 months ago
|
TradeWithAlerts
Follow
3 years, 3 months ago
|
Paul Meakem
Follow
3 years, 3 months ago
|
Sector | Healthcare |
---|---|
ISIN | US0028241000 |
CurrencyCode | USD |
Exchange | NYSE |
Industry | Medical Devices |
Target Price | 122.49 |
---|---|
Market Cap | 180B |
Dividend Yield | 2.0% |
Beta | 0.67 |
PE Ratio | 25.1 |
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ABT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024